Intuitive Surgical stock falls 2.32 percent before Q3 results

Published on 10/03/2026 at 23:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock stood at USD 391.95 on October 2, 2026, 35.1 percent below its 52-week high. Q2 EPS reached USD 2.80 versus USD 2.48 consensus.

Isometrische 3D-Grafik zeigt Labor, Fertigung, Operationssaal und Trainingszentrum als Prozesskette — Isometrische 3D-Illustration der Wertschöpfungskette stellt Intuitive Surgical Inc. (US46120E6023) von Forschung bis Operationssaal-Anwendung dar, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) closed at USD 391.95 on Nasdaq on October 2, 2026, down 2.32 percent from the prior session. The move leaves the medical device company 35.1 percent below its 52-week high of USD 603.88 as investors weigh strong quarterly execution against slower growth expectations.

Q2 earnings beat estimates

MarketBeat reported that Intuitive Surgical delivered USD 2.80 in earnings per share for Q2 2026, above the USD 2.48 consensus estimate, while revenue reached USD 2.89 billion against USD 2.83 billion expected. Revenue increased 18.4 percent from the prior-year quarter, giving the latest results a clear operational counterweight to the stock's 30.79 percent year-to-date decline.

The same Q2 report showed a 28.45 percent net margin, while the finance data snapshot lists USD 1.061 billion in operating cash flow for the quarter ended June 30, 2026. Together, those figures point to a profitable business with substantial cash generation even as the market applies a lower valuation to its near-term growth.

China tests the growth model

International expansion is becoming more important as China weighs on the regional picture. A Yahoo Finance report on October 2, 2026, said international da Vinci procedures rose 20 percent in Q2, while Intuitive Surgical maintained 2026 procedure growth guidance of 13.5 percent to 15.5 percent.

The regional split matters because the report identified lower tender activity, domestic robotic competition and pricing pressure as China headwinds. India and Japan supplied a more constructive contrast, with da Vinci 5 clearance in India and 25 systems placed in Japan versus 15 a year earlier.

Stock heads into October 20

The next measurable catalyst is the Q3 2026 earnings release. MarketBeat lists October 20, 2026, after the market close, with consensus EPS of USD 2.64 and expected revenue of USD 2.91 billion.

Analyst support remains visible but sits well above the market price. MarketBeat said BTIG reaffirmed a Buy rating and a USD 469 price target on September 8, 2026, while its reported consensus target stood at USD 508.68.

Valuation meets execution

Intuitive Surgical's reference price was USD 391.95 on Nasdaq at the October 2, 2026 close, with 1,826,723 shares traded and a market capitalization of USD 138.5 billion. The 52-week range was USD 328.57 to USD 603.88, so the stock sat 19.3 percent above its low while remaining materially below its high.